Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine
Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine
Recruiting · NCT07416656 · Registry updated 2026-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine | Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, type 1 diabetes mellitus, type 2 diabetes mellitus | Recruiting | Not stated | 2026-06-25 | NCT07416656 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Klavs Würgler Hansen | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medical Diagnostic Center | Silkeborg | Denmark | 1 |